TickerLeague

Buyback Spend for Zoetis (ZTS)

Buyback Spend for Zoetis (ZTS): headline value $3.23B · YoY +74.1%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$3.23B

YoY change

+74.1%

5Y CAGR

+66.9%

Peak year (2025)

$3.23B

Latest annual

$3.23B

Buyback Spend history chart for Zoetis (ZTS) from 2009 to 2025

Buyback Spend history table for Zoetis (ZTS) from 2009 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$3.23B+74.1%
2024$1.86B+70.1%
2023$1.09B-31.5%
2022$1.59B+114.5%
2021$743.00M+197.2%
2020$250.00M-60.1%
2019$626.00M-10.3%
2018$698.00M+39.6%
2017$500.00M+66.7%
2016$300.00M+47.8%
2015$203.00M
2014$0
2013$0
2012$0
2011$0
2010$0
2009$0

Buyback Spend values are taken from Zoetis's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Zoetis (ZTS) reported buyback spend of $3.23B – surged 74.1% year-over-year.

Across 2020–2025 (5 years), Zoetis buyback spend produced a CAGR of +66.9% – sustaining 2 straight years of year-over-year growth.

$3.23B stands as the all-time-high annual buyback spend, posted in 2025, against a low of $0 during 2009.

Within Healthcare, Zoetis (ZTS) ranks 5th among 8 peers we track. The peer median for buyback spend is $2.75B.

Zoetis Buyback Spend by Year

Zoetis Buyback Spend 2025: $3.23B

Zoetis buyback spend in 2025 was $3.23B, surged 74.1% from 2024. This figure represents the highest annual value in the available history.

Zoetis Buyback Spend 2024: $1.86B

Zoetis buyback spend in 2024 was $1.86B, surged 70.1% from 2023.

Zoetis Buyback Spend 2023: $1.09B

Zoetis buyback spend in 2023 was $1.09B, plunged 31.5% below 2022.

Zoetis Buyback Spend 2022: $1.59B

Zoetis buyback spend in 2022 was $1.59B, surged 114.5% from 2021.

Zoetis Buyback Spend 2021: $743.00M

Zoetis buyback spend in 2021 was $743.00M.

See more financial history for Zoetis (ZTS).

Sector peers — Buyback Spend

Companies in the same sector as Zoetis, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Zoetis's buyback spend?

Latest reported buyback spend for Zoetis (ZTS) is $3.23B (period ending December 31, 2025).

How has Zoetis buyback spend changed year-over-year?

Zoetis (ZTS) buyback spend changed +74.1% year-over-year on the latest annual filing.

What is the long-term growth rate of Zoetis buyback spend?

Zoetis (ZTS) buyback spend compound annual growth rate is +66.9% over the most recent 5 years available.

When did Zoetis buyback spend hit its highest annual value?

Zoetis buyback spend reached its highest annual value of $3.23B in 2025.

What was Zoetis buyback spend in 2024?

Zoetis (ZTS) buyback spend in 2024 was $1.86B.

What was Zoetis buyback spend in 2025?

Zoetis (ZTS) buyback spend in 2025 was $3.23B.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.